GRS Home

The Growth Hormone Research Society

Pituitary

The 10th International Congress of the Growth Hormone Research Society
May10-11, 2024 - Stockholm, Sweden


Date and time
Friday 10 - Saturday 11 May 2024. This event will start at approximately 09:00 on Friday and will finish in time for delegates to attend the ECE 2024 Opening Ceremony.

Location
ECE 2024 venues - Stockholmsmässan (www.stockholmsmassan.se), Room TBC

Program
The meeting will provide an update on basic, translational and clinical research in the field of growth hormone related diseases. The format includes plenaries from leading experts in the field, and abstract based oral and poster sessions.
Follow this link for the program

Submission of Abstracts
Abstracts for this Congress must be submitted by email to the Growth Hormone Research Society (GRS): grs@clin.au.dk. Guidelines for preparation and submission of abstracts can be found here. Abstract submission deadline for the GRS congress is Friday 1 March 2024. Notification to authors of abstract acceptance/rejection - Mid-March 2024.

GRS and ESE encourage that abstracts submitted to the GRS congress are also submitted to ECE 2024 and published in Endocrine Abstracts. Note that abstract submission deadline for ECE is Monday 22 January 2024. For more details about submission of abstracts to ECE 2024 please refer to https://www.ese-hormones.org/events-deadlines/european-congress-of-endocrinology/ece-2024/abstracts-and-posters/.

NB - You must be registered for the corresponding Congresses in order to present or be published at either meeting.

Delegate fee (GRS congress only)
In-person = 100 Euro
In-person (in-training, nurse, Early Career) = 50 Euro

NB - there is not an option to attend this congress online. The registration fees shown here do not include registration for ECE2024.

Travel grants
More than 50 travel grants are available from GRS for early career attendees who present an abstract.
Follow this link for details

Registration details
You must register for this event through your ECE 2024 registration (you do not have to attend ECE 2024, but your registration will only be valid for the Pre-Congress Course).
Follow this link to register https://www.ese-hormones.org/events-deadlines/european-congress-of-endocrinology/ece-2024/registration/

Contact
For further information, please contact the ECE 2024 Congress team on ece2024@endocrinology.org or send an email to GRS at grs@clin.au.dk

Consensus Statements


The GRS sponsors consensus statements on GH-related issues. These consensus statements shown below can be downloaded as pdf files (with permission from the publisher) and viewed using Adobe Acrobat Reader v.5.0 or greater. The pdf files include a list of the participants in the consensus workshops.

Safety of Growth Hormone Replacement in Survivors of Cancer and Intracranial and Pituitary Tumours: A Consensus Statement.pdf
Eur J Endocrinol. 2022 Apr 21;186(6):35-52. doi: 10.1530/EJE-21-1186.
2022 Online:

Diagnosis, Genetics, and Therapy of Short Stature in Children: A Growth Hormone Research Society International Perspective.pdf
Horm Res Paediatr. 2019 Sep 12:1-14. doi: 10.1159/000502231. [Epub ahead of print]
2019 Lisbon, Portugal:

Growth Hormone Research Society perspective on biomarkers of GH action in children and adults.pdf
Endocr Connect. 2018 Mar;7(3):R126-R134)
2017 Aarhus, Denmark:

Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations.pdf
Eur J Endocrinol. 2016 Jun;174(6):C1-8. doi: 10.1530/EJE-16-0111. Epub 2016 Mar 23.
2015 Pacific Grove, California, USA:

Growth Hormone Safety Workshop Position Paper: a critical appraisal of recombinant human growth hormone therapy in children and adults.pdf
Eur J Endocrinol. 2015 Nov 12. pii: EJE-15-0873. [Epub ahead of print]
2014 Manchester, England:

Growth Hormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome.pdf
J Clin Endocrinol Metab. 2013 Jun;98(6):E1072-87
2011 Montreal, Canada:

Consensus Statement on the Standardization and Evaluation of Growth Hormone and Insulin-like Growth Factor Assays.pdf
Clin. Chem. 57: 555-559, 2011
2009 Keswick, Virginia, USA:

Statement by the Growth Hormone Research Society on the GH/IGF-I Axis in Extending Health Span.pdf
J Gerontol A Biol Sci Med Sci 64A: 1039-1044, 2009
2008 Reykjavik, Iceland:

Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia.pdf
Eur J Endocrinol 157: 695-700, 2007
2007 Sydney, Australia:

Consensus Statement on the Diagnosis and Treatment of Children with Idiopathic Short Stature: A Summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop.pdf
J Clin Endocrinol Metab 93: 4210?4217, 2008
2007 Santa Monica, California, USA:

Management of the Child Born Small for Gestational Age through to Adulthood: A Consensus Statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society.pdf
J Clin Endocrinol Metab 92: 2006-2017, 2007
2006 Manchester, UK:

Consensus statement on the management of the GH-treated adolescent in the transition to adult care.pdf
Eur J Endocrinol 152:165-170, 2005
2003 Manchester, UK:

Biochemical Assessment and Long-Term Monitoring in Patients with Acromegaly: Statement from a Joint Consensus Conference of The Growth Hormone Research Society and The Pituitary Society.pdf
J Clin Endocrinol Metab 89: 3099-3102, 2004
2003: Feldafing, Germany:

Critical Evaluation of the Safety of Recombinant Human Growth Hormone Administration: Statement from the Growth Hormone Research Society.pdf
J Clin Endocrinol Metab 86: 1868?1870, 2001
2000: Keswick, Virginia, USA:
The consensus can also be presented with the following: Keswick.ppt.

Consensus Guidelines for the Diagnosis and Treatment of Growth Hormone (GH) Deficiency in Childhood and Adolescence: Summary Statement of the GH Research Society.pdf
J Clin Endocrinol Metab 83: 3990?3993, 2000
1999: Eilat, Israel:
The consensus can also be presented with the following: Eilat.ppt

Consensus Guidelines for the Diagnosis and Treatment of Adults with Growth Hormone Deficiency: Summary Statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency.pdf
J Clin Endocrinol Metab 83: 379?381, 1998
1997: Port Stevens, New South Wales, Australia:
The consensus can also be presented with the following: Stephen6.ppt

 

 

Constitution

 

Consensus Statements

 

Honorary Members

 

hGH Indications

 

Officers

IGF Society

Links